Fluorescence Resonance Energy Transfer (FRET) is an approach widely used to detect protein-protein interactions in live cells. This approach is based on the sensitization of an "acceptor" molecule by the energy transfer from a "donor" when there is an overlap between the emission spectrum of the "donor" and the excitation spectrum of the "acceptor" and close proximity between the two fluorophore species (in the region of 8 nm). Various methods exist to quantify FRET signals: here we describe the application of homogeneous timeresolved FRET (htrFRET) combined with Tag-lite TM technology and its application to determine not only protein-protein interactions but also the capability of GPCR mutant variants to form homomers compared to the wild type GPCR within the plasma membrane of transfected cells.
Introduction
G protein-coupled receptors (GPCRs) are a vast class of trans-plasma membrane proteins that play pivotal roles in cell signalling and in the regulation of a broad range of biological processes. Dysregulation of many of these result in serious pathological conditions and, as such, GPCRs represent a major target class for therapeutic drug development (1) .
GPCRs have been classically described as monomeric units that bind in a stoichiometric 1:1 ratio to both ligand and downstream signalling proteins such as members of the family of heterotrimeric guanine nucleotide binding proteins (G-proteins). Indeed, studies in which monomeric GPCRs were incorporated into nanodiscs demonstrated that each of the ² 2 -adrenoceptor, rhodopsin, and the µ-opioid receptor can function effectively as monomers (2, 3, 4, 5). However, in recent years a growing number of studies have supported the hypothesis that GPCRs may also exist as dimeric or oligomeric complexes (6, 7). In the case of various members of the class C, metabotropic glutamate receptor family it is clear that formation of either homo-or hetero-complexes define the pharmacology and function of the receptor (7).
However, in the case of the more numerous class A, rhodopsin-like receptors, the situation is more uncertain and both the basic concept of GPCR oligomerization and its functional relevance remain controversial topics (6).
The first structural evidence supporting organization of a class A GPCR into dimers/oligomers was provided by the application of atomic force microscopy to murine rod outer segment discs that indicated that rhodopsin is arranged as a series of parallel arrays of dimers (8). Since 2007 innovative crystallographic techniques have resulted in rapid growth in the number of available atomic level GPCR structures (9). Such structures are consistent with, for example, the µ-opioid and the ² 1 -adrenoceptor, being able to organize as parallel dimers and/or tetramers, and suggest the existence of multiple dimer interfaces in different GPCR homodimers. Transmembrane domain (TMD) V and TMD VI residues provide the main interface for µ-opioid receptor dimers while TMD I, TMD II and helix 8 residues generate a second, more limited, interface (10). A TMD I-TMD II-helix 8 interface (with slightly different contact residues) was also found in crystals of the turkey ² 1 -adrenoceptor (11) where it constitutes the most prominent interaction interface. An additional interface involving TMD IV and TMD V residues was also observed for this receptor (11).
Both biochemical and biophysical approaches have been employed to study the basis of GPCRs dimerization/oligomerization (12). However, traditional biochemical techniques such as immunoblotting, cross-linking and co-immunoprecipitation, have clear limitations in efforts to study interactions involving integral membrane proteins owing to the need to use non-physiological buffers and detergents that may cause aggreration or disruption of native biological interactions.
In the past decade, several biophysical methods based on Resonance Energy Transfer (RET) between two molecules, known as the "donor" and "acceptor", have been developed to examine the quaternary organization of integral membrane proteins, including GPCRs, in intact cells. These include both Bioluminesence Resonance Energy Transfer (BRET) and Fluorescence Resonance Energy Transfer (FRET). Moreover, when combined with protein complementation assays that allow the reconstitution of a fluorophore from two nonfluorescent polypeptides that are brought into proximity by interactions between the proteins they are attached to, larger scale complexes can, at least potentially, be detected and imaged.
Although these techniques overcome a number of the issues with the biochemical approaches noted above, they both generally require genetic manipulation of the proteins, thus limiting in vivo analysis without a committed effort to generate transgenic organisms and report proximity between proteins rather than association per se.
In this chapter we describe the application of homogenous time-resolved FRET (htrFRET) using SNAP- Tag 11. Miniprep kit.
Cell Culture

Suitable cells for transfection (e.g. Human Embryonic Kidney 293 cells, HEK293T cells).
2. Suitable growth medium, such as Dulbecco´s Modified Eagle´s medium containing 0.292 g/L L-glutamine, 1% penicillin/streptomycin mixture and 10% heat-inactivated fetal bovine serum.
3. Cell culture dishes 60 mm x 15 mm style.
Transfection reagent such as polyethylenimine (PEI).
5. Sodium chloride: 150mM NaCl. Autoclave at 121°C, 15 min and store at room temperature.
6. Poly-D-lysine: 0.1mM poly-D-lysine dissolved in sterile tissue culture grade water. Store at 4°C.
7. Trypsin.
HtrFRET assay
1. Dimethyl sulfoxide (DMSO).
2. Phosphate buffered saline (PBS, 10X): 1370mM NaCl, 27mM KCl, 100mM Na 2 HPO 4, 20mM KH 2 PO 4 dissolved in distilled water. Store at room temperature. To obtain the working solution, PBS 1X, dilute PBS 10X in distilled water in a ratio 1:9 and assess the pH of the solution that must be 7.4.
3. Black 96 well plate (Greiner Bio-One).
4. SNAP-Lumi4Tb (Cisbio).
SNAP-Red (Cisbio).
6. Labeling medium 5X (Cisbio).
Equipment
1. Standard cell culture facility including biological safety cabinet and 37°C incubator with 5% CO 2 .
2. Thermal cycler.
3. Microplate reader (such as Pherastar BMG Labtech).
4. GraphPad Prism 5.2 software for data analysis. 2. Generate the SNAP-tag-GPCR mutant variants using a modification of the QuikChange method (Stratagene, Agilent Technologies, Santa Clara, CA). To amplify the SNAP-tag-GPCR construct and introduce the desired mutation combine in a sterile nuclease-free microcentrifuge tube the PCR reaction components in a total volume of 50 µL ( Table 1) .
Prepare also a PCR control reaction without including the Pfu DNA polymerase. 6. Select 3 colonies randomly and grow them overnight in 5 mL LB-Broth. The next day isolate the plasmids using miniprep kit (follow manufacturer`s protocol) (see Note 2).
7. Check the presence of mutation in the isolated plasmids by sequencing.
Transient expression in mammalian cells
1. Plate mammalian cells onto 60 mm cell culture dishes and grow to 70-80% confluency overnight at 37 °C with 5% CO 2 . 7. Aspirate the cell growth medium and replace it, adding to each well 50 µL of one of each solution made in the step 4 (see Note 5). This step is performed in day 3.
Transfect the cells with the plasmid of interest following the PEI protocol (16)
.
Incubate the plates for 1 h at 37°C in a humidified atmosphere (5% CO 2 ), (see Note 4).
This step is performed in day 3.
9. Aspirate the SNAP-Lumi4Tb and SNAP-Red containing medium and wash the plate 4 times with 100 µL PBS 1X. This step is performed in day 3.
10. Add 100 µL of labeling medium 1X. This step is performed in day 3. 4. Incubate for 1 h at 37°C in a humidified atmosphere (5% CO 2 ) (see Note 5). This step is performed in day 3.
5. Aspirate the SNAP-Lumi4Tb and SNAP-Red mixture and wash the plate 4 times with 100 µL PBS 1X. This step is performed in day 3.
6. Add 100 µL of labeling medium 1X. This step is performed in day 3.
7. Measure the fluorescence emission using a microplate reader (Pherastar) as described in step 11 section 3.4. This step is performed in day 3.
8. Analyse the data using GraphPad Prism 5.2 (or similar) software, plot the fluorescence emission at 620 nm on the X axis and the htrFRET signal at 665 nm on the Y axis and apply linear regression curve fit analysis to each dataset (Figure 3 ). 4. Notes 
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